These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25636510)

  • 1. Capn4 promotes non-small cell lung cancer progression via upregulation of matrix metalloproteinase 2.
    Gu J; Xu FK; Zhao GY; Lu CL; Lin ZW; Ding JY; Ge D
    Med Oncol; 2015 Mar; 32(3):51. PubMed ID: 25636510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capn4 is a marker of poor clinical outcomes and promotes nasopharyngeal carcinoma metastasis via nuclear factor-κB-induced matrix metalloproteinase 2 expression.
    Zheng PC; Chen X; Zhu HW; Zheng W; Mao LH; Lin C; Liu JN; Zheng M
    Cancer Sci; 2014 Jun; 105(6):630-8. PubMed ID: 24703594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of Capn4 overexpression in intrahepatic cholangiocarcinoma.
    Zhang C; Bai DS; Huang XY; Shi GM; Ke AW; Yang LX; Yang XR; Zhou J; Fan J
    PLoS One; 2013; 8(1):e54619. PubMed ID: 23349941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capn4 contributes to tumor invasion and metastasis in gastric cancer via activation of the Wnt/β-catenin/MMP9 signalling pathways.
    Zhao C; Yuan G; Jiang Y; Xu J; Ye L; Zhan W; Wang J
    Exp Cell Res; 2020 Oct; 395(2):112220. PubMed ID: 32777225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of astrocyte-elevated gene-1 is closely correlated with poor prognosis in human non-small cell lung cancer and mediates its metastasis through up-regulation of matrix metalloproteinase-9 expression.
    Sun S; Ke Z; Wang F; Li S; Chen W; Han A; Wang Z; Shi H; Wang LT; Chen X
    Hum Pathol; 2012 Jul; 43(7):1051-60. PubMed ID: 22204714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
    Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
    Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9.
    Dong QZ; Wang Y; Tang ZP; Fu L; Li QC; Wang ED; Wang EH
    Am J Pathol; 2013 Mar; 182(3):954-64. PubMed ID: 23306155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capn4 contributes to tumour growth and metastasis of hepatocellular carcinoma by activation of the FAK-Src signalling pathways.
    Dai Z; Zhou SL; Zhou ZJ; Bai DS; Xu XY; Fu XT; Chen Q; Zhao YM; Zhu K; Yu L; Yang GH; Wang Z; Wu WZ; Zhou J; Fan J
    J Pathol; 2014 Nov; 234(3):316-28. PubMed ID: 24962955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LATS2 as a poor prognostic marker regulates non-small cell lung cancer invasion by modulating MMPs expression.
    Wu A; Li J; Wu K; Mo Y; Luo Y; Ye H; Mai Z; Guo K; Wang Y; Li S; Chen H; Luo W; Yang Z
    Biomed Pharmacother; 2016 Aug; 82():290-7. PubMed ID: 27470365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visfatin Triggers the Cell Motility of Non-Small Cell Lung Cancer via Up-Regulation of Matrix Metalloproteinases.
    Wang G; Tian W; Liu Y; Ju Y; Shen Y; Zhao S; Zhang B; Li Y
    Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):548-554. PubMed ID: 27224551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High NUAK1 expression correlates with poor prognosis and involved in NSCLC cells migration and invasion.
    Chen P; Li K; Liang Y; Li L; Zhu X
    Exp Lung Res; 2013 Feb; 39(1):9-17. PubMed ID: 23215946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer.
    Gu J; Ding JY; Lu CL; Lin ZW; Chu YW; Zhao GY; Guo J; Ge D
    Lung Cancer; 2013 Aug; 81(2):259-65. PubMed ID: 23706417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capn4 overexpression underlies tumor invasion and metastasis after liver transplantation for hepatocellular carcinoma.
    Bai DS; Dai Z; Zhou J; Liu YK; Qiu SJ; Tan CJ; Shi YH; Huang C; Wang Z; He YF; Fan J
    Hepatology; 2009 Feb; 49(2):460-70. PubMed ID: 19053044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
    Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DIXDC1 increases the invasion and migration ability of non-small-cell lung cancer cells via the PI3K-AKT/AP-1 pathway.
    Xu Z; Liu D; Fan C; Luan L; Zhang X; Wang E
    Mol Carcinog; 2014 Nov; 53(11):917-25. PubMed ID: 23813858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and clinical significance of matrix metalloproteinase (MMP)-26 protein in non-small cell lung cancer.
    Li L; Mei TH; Zhou XD; Zhang XG
    Ai Zheng; 2009 Jan; 28(1):60-3. PubMed ID: 19448419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of flotillin-2 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
    Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Wang ZM
    Int J Clin Exp Pathol; 2015; 8(1):601-7. PubMed ID: 25755751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated expression of ILF2 in non-small cell lung cancer is associated with tumor cell proliferation and poor prognosis.
    Ni T; Mao G; Xue Q; Liu Y; Chen B; Cui X; Lv L; Jia L; Wang Y; Ji L
    J Mol Histol; 2015 Oct; 46(4-5):325-35. PubMed ID: 26059795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer.
    Liu H; Gu Y; Wang H; Yin J; Zheng G; Zhang Z; Lu M; Wang C; He Z
    Oncotarget; 2015 Jun; 6(17):14913-25. PubMed ID: 25945834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capn4 mRNA level is correlated with tumour progression and clinical outcome in clear cell renal cell carcinoma.
    Zhuang Q; Qian X; Cao Y; Fan M; Xu X; He X
    J Int Med Res; 2014 Apr; 42(2):282-91. PubMed ID: 24514433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.